404 related articles for article (PubMed ID: 7859402)
21. Raynaud's phenomenon and related vasospastic disorders.
Choi E; Henkin S
Vasc Med; 2021 Feb; 26(1):56-70. PubMed ID: 33566754
[TBL] [Abstract][Full Text] [Related]
22. Raynaud's phenomenon: pathogenesis and management.
Bakst R; Merola JF; Franks AG; Sanchez M
J Am Acad Dermatol; 2008 Oct; 59(4):633-53. PubMed ID: 18656283
[TBL] [Abstract][Full Text] [Related]
23. Raynaud's phenomenon.
Block JA; Sequeira W
Lancet; 2001 Jun; 357(9273):2042-8. PubMed ID: 11438158
[TBL] [Abstract][Full Text] [Related]
24. [Raynaud's phenomenon].
Sprynger M
Rev Med Liege; 2004 Jun; 59(6):378-84. PubMed ID: 15346976
[TBL] [Abstract][Full Text] [Related]
25. Raynaud's phenomenon.
Lally EV
Curr Opin Rheumatol; 1992 Dec; 4(6):825-36. PubMed ID: 1457277
[TBL] [Abstract][Full Text] [Related]
26. Raynaud's phenomenon of the nipple: a treatable cause of painful breastfeeding.
Anderson JE; Held N; Wright K
Pediatrics; 2004 Apr; 113(4):e360-4. PubMed ID: 15060268
[TBL] [Abstract][Full Text] [Related]
27. 25. Ischemic pain in the extremities and Raynaud's phenomenon.
Devulder J; van Suijlekom H; van Dongen R; Diwan S; Mekhail N; van Kleef M; Huygen F
Pain Pract; 2011; 11(5):483-91. PubMed ID: 21435165
[TBL] [Abstract][Full Text] [Related]
28. Raynaud's phenomenon of the lung.
Fahey PJ; Utell MJ; Condemi JJ; Green R; Hyde RW
Am J Med; 1984 Feb; 76(2):263-9. PubMed ID: 6695950
[TBL] [Abstract][Full Text] [Related]
29. [Raynaud's phenomenon - first sign of malignancy: case report].
Sutić A; Gračanin G; Morović-Vergles J
Acta Med Croatica; 2014 Jun; 68(3):295-8. PubMed ID: 26016221
[TBL] [Abstract][Full Text] [Related]
30. Occlusive digital artery disease in patients with Raynaud's phenomenon.
Zweifler AJ; Trinkaus P
Am J Med; 1984 Dec; 77(6):995-1001. PubMed ID: 6334442
[TBL] [Abstract][Full Text] [Related]
31. [Botulinum toxin type A contribution in the treatment of Raynaud's phenomenon due to systemic sclerosis].
Serri J; Legré R; Veit V; Guardia C; Gay AM
Ann Chir Plast Esthet; 2013 Dec; 58(6):658-62. PubMed ID: 22204894
[TBL] [Abstract][Full Text] [Related]
32. Raynaud's phenomenon.
Herrick AL; Wigley FM
Best Pract Res Clin Rheumatol; 2020 Feb; 34(1):101474. PubMed ID: 32007400
[TBL] [Abstract][Full Text] [Related]
33. Dystrophic calcifications and Raynaud's phenomenon in an eight-year old girl.
Grebeldinger SP; Tomić JM; Vijatov-Djurić GV; Radojcić BS; Vucković NM; Culafić JN
Srp Arh Celok Lek; 2014; 142(3-4):239-42. PubMed ID: 24839783
[TBL] [Abstract][Full Text] [Related]
34. Raynaud's phenomenon: primary and secondary causes.
Balas P; Tripolitis AJ; Kaklamanis P; Mandalaki T; Paracharalampous N
Arch Surg; 1979 Oct; 114(10):1174-7. PubMed ID: 485828
[TBL] [Abstract][Full Text] [Related]
35. Managing Raynaud's phenomenon: a practical approach.
Adee AC
Am Fam Physician; 1993 Mar; 47(4):823-9. PubMed ID: 8438681
[TBL] [Abstract][Full Text] [Related]
36. Botulinum toxin type A in the treatment of Raynaud's phenomenon.
Habib SM; Brenninkmeijer EEA; Vermeer MH; de Vries-Bouwstra JK; Velthuis PJ
Dermatol Ther; 2020 Nov; 33(6):e14182. PubMed ID: 32794364
[TBL] [Abstract][Full Text] [Related]
37. How to classify Raynaud's phenomenon. Long-term follow-up study of 73 cases.
Priollet P; Vayssairat M; Housset E
Am J Med; 1987 Sep; 83(3):494-8. PubMed ID: 3661586
[TBL] [Abstract][Full Text] [Related]
38. A Review of Raynaud's Disease.
Temprano KK
Mo Med; 2016; 113(2):123-6. PubMed ID: 27311222
[TBL] [Abstract][Full Text] [Related]
39. Laser Doppler skin perfusion pressure in the assessment of Raynaud's phenomenon.
Kanetaka T; Komiyama T; Onozuka A; Miyata T; Shigematsu H
Eur J Vasc Endovasc Surg; 2004 Apr; 27(4):414-6. PubMed ID: 15015193
[TBL] [Abstract][Full Text] [Related]
40. Fish-oil dietary supplementation in patients with Raynaud's phenomenon: a double-blind, controlled, prospective study.
DiGiacomo RA; Kremer JM; Shah DM
Am J Med; 1989 Feb; 86(2):158-64. PubMed ID: 2536517
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
